These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9589437)

  • 41. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Pap smear: a victim of its own success?
    Steigman CK; Vernick JP
    MLO Med Lab Obs; 2002 Aug; 34(8):8-14; quiz 14-5. PubMed ID: 12228932
    [No Abstract]   [Full Text] [Related]  

  • 43. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD; Lin RS
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Papanicolaou smear screening augmented by a magnified chemiluminescent exam.
    Mann W; Lonky N; Massad S; Scotti R; Blanco J; Vasilev S
    Int J Gynaecol Obstet; 1993 Dec; 43(3):289-96. PubMed ID: 7907040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
    Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
    Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whatever happened to the annual pap smear?
    Vigliani MB
    R I Med J (2013); 2013 Jan; 96(1):36-8. PubMed ID: 23638458
    [No Abstract]   [Full Text] [Related]  

  • 48. The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix.
    Michalas SP
    Eur J Obstet Gynecol Reprod Biol; 2000 Jun; 90(2):135-8. PubMed ID: 10825631
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
    Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
    Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Factors associated with women's failure to submit to Pap smears: a population-based study in Campinas, São Paulo, Brazil].
    Amorim VM; Barros MB; César CL; Carandina L; Goldbaum M
    Cad Saude Publica; 2006 Nov; 22(11):2329-38. PubMed ID: 17091170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for cervical cancer. Current terminology, classification, and technique.
    Fowler J
    Postgrad Med; 1993 Feb; 93(2):57-64, 70. PubMed ID: 8381956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compliance behavior in women with abnormal Pap smears. Developing and testing a decision model.
    Paskett ED; Carter WB; Chu J; White E
    Med Care; 1990 Jul; 28(7):643-56. PubMed ID: 2366603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integration of cervical screening in family planning clinics.
    Claeys P; De Vuyst H; Mzenge G; Sande J; Dhondt V; Temmerman M
    Int J Gynaecol Obstet; 2003 Apr; 81(1):103-8. PubMed ID: 12676408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Women's knowledge of Pap smear test and human papillomavirus: acceptance of HPV vaccination to themselves and their daughters in an Islamic society.
    Ilter E; Celik A; Haliloglu B; Unlugedik E; Midi A; Gunduz T; Ozekici U
    Int J Gynecol Cancer; 2010 Aug; 20(6):1058-62. PubMed ID: 20683417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Women at risk: papanicolaou smear screening in Florida.
    Vincent AL; Greene JN; Hoercherl S; McTague D
    J Fla Med Assoc; 1997; 84(5):302-7. PubMed ID: 9260433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
    Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
    J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
    Nieminen P; Kallio M; Anttila A; Hakama M
    Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.